2004
Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities
Garfein R, Monterroso E, Tong T, Vlahov D, Des Jarlais D, Selwyn P, Kerndt P, Word C, Fernando M, Ouellet L, Holmberg S. Comparison of HIV infection risk behaviors among injection drug users from East and West Coast US cities. Journal Of Urban Health 2004, 81: 260-267. PMID: 15136659, PMCID: PMC3456450, DOI: 10.1093/jurban/jth112.Peer-Reviewed Original ResearchConceptsInjection drug usersRisk behaviorsHIV seroprevalenceHigh human immunodeficiency virus (HIV) seroprevalenceDrug usersHIV infection risk behaviorsHuman immunodeficiency virus (HIV) seroprevalenceInfection risk behaviorsPotential risk factorsHIV risk behaviorsHIV incidenceHIV statusRisk factorsVirus seroprevalenceSexual partnersPrevention effortsSeroprevalenceBaseline dataHIVFace interviewsInjectionNew York CityFurther effortsNew HavenParticipants
1994
The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users.
Astemborski J, Vlahov D, Warren D, Solomon L, Nelson K. The trading of sex for drugs or money and HIV seropositivity among female intravenous drug users. American Journal Of Public Health 1994, 84: 382-7. PMID: 8129052, PMCID: PMC1614821, DOI: 10.2105/ajph.84.3.382.Peer-Reviewed Original ResearchConceptsFemale intravenous drug usersIntravenous drug usersHIV seropositivityHIV infectionDrug usersHuman immunodeficiency virus (HIV) seroprevalenceIntravenous drug useDrug-using womenTrading of sexCohort studyVirus seroprevalenceDrug useCocaine useIntensive interventionLogistic regressionSeropositivityNumber of partnersMultivariate modelDrugsWomenSexInfectionGroupHigh levelsSeroprevalence
1991
Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users
Nelson K, Vlahov D, Cohn S, Lindsay A, Solomon L, Anthony J. Human Immunodeficiency Virus Infection in Diabetic Intravenous Drug Users. JAMA 1991, 266: 2259-2261. PMID: 1920726, DOI: 10.1001/jama.1991.03470160091038.Peer-Reviewed Original ResearchConceptsHistory of diabetesIntravenous drug usersDrug usersHIV seroprevalenceDrug useHuman immunodeficiency virus (HIV) seroprevalenceHuman immunodeficiency virus (HIV) infectionLow HIV seroprevalenceImmunodeficiency virus infectionSafe injection practicesApparent protective effectSterile injection equipmentCross-sectional surveyHIV infectionStudy clinicInjection paraphernaliaVirus seroprevalenceVirus infectionDrug treatmentProtective effectInjection practicesDiabetesPast monthSeroprevalenceSimilar duration